[Mastocytosis: general anesthesia with remifentanil and sevoflurane]. 2001

L Auvray, and B Letourneau, and M Freysz
Département d'anesthésie-réanimation, CHU, hôpital Général, 21033 Dijon, France.

Mastocytosis is a disorder with potential anaesthesia complications. Reviewing the literature, anaesthetic management of mastocytosis is controversial. We report the successful use of remifentanil and sevoflurane in a woman with systemic mastocytosis. No reaction nor histamine release was observed in these cases.

UI MeSH Term Description Entries
D008415 Mastocytosis A rare neoplastic disorder characterized by a clonal proliferation of MAST CELLS, associated with KIT-D816 mutations, and accompanied by aberrant mast cell activation. The abnormal increase of MAST CELLS may occur in only the skin (MASTOCYTOSIS, CUTANEOUS), in extracutaneous tissues involving multiple organs (MASTOCYTOSIS, SYSTEMIC), or in solid tumors (MASTOCYTOMA).
D008738 Methyl Ethers A group of compounds that contain the general formula R-OCH3. Ethers, Methyl
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010880 Piperidines A family of hexahydropyridines.
D005260 Female Females
D006636 Histamine Release The secretion of histamine from mast cell and basophil granules by exocytosis. This can be initiated by a number of factors, all of which involve binding of IgE, cross-linked by antigen, to the mast cell or basophil's Fc receptors. Once released, histamine binds to a number of different target cell receptors and exerts a wide variety of effects. Histamine Liberation,Histamine Liberations,Histamine Releases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077149 Sevoflurane A non-explosive inhalation anesthetic used in the induction and maintenance of general anesthesia. It does not cause respiratory irritation and may also prevent PLATELET AGGREGATION. BAX 3084,Fluoromethyl Hexafluoroisopropyl Ether,Fluoromethyl-2,2,2-trifluoro-1-(trifluoromethyl)ethyl Ether,Sevorane,Ultane
D000077208 Remifentanil A piperidine-propionate derivative and opioid analgesic structurally related to FENTANYL. It functions as a short-acting MU OPIOID RECEPTOR agonist, and is used as an analgesic during induction or maintenance of general anesthesia, following surgery, during childbirth, and in mechanically ventilated patients under intensive care. 3-(4-Methoxycarbonyl-4-((1-oxopropyl)phenylamino)-1-piperidine)propanoic Acid Methyl Ester,GI 87084B,GI-87084B,GI87084B,Remifentanil Hydrochloride,Remifentanil Monohydrochloride,Ultiva
D000759 Adjuvants, Anesthesia Agents that are administered in association with anesthetics to increase effectiveness, improve delivery, or decrease required dosage. Anesthesia Adjuvants,Anesthetic Adjuvants,Adjuvants, Anesthetic

Related Publications

L Auvray, and B Letourneau, and M Freysz
January 2013, Masui. The Japanese journal of anesthesiology,
L Auvray, and B Letourneau, and M Freysz
October 2010, Korean journal of anesthesiology,
L Auvray, and B Letourneau, and M Freysz
December 2009, Korean journal of anesthesiology,
L Auvray, and B Letourneau, and M Freysz
November 2007, Masui. The Japanese journal of anesthesiology,
L Auvray, and B Letourneau, and M Freysz
October 1995, The Medical letter on drugs and therapeutics,
L Auvray, and B Letourneau, and M Freysz
September 2014, Masui. The Japanese journal of anesthesiology,
L Auvray, and B Letourneau, and M Freysz
December 2019, Anesthesiology,
L Auvray, and B Letourneau, and M Freysz
September 2013, Veterinary anaesthesia and analgesia,
Copied contents to your clipboard!